KDM1A (LSD1) Antibody - FFPE Validated

Protein Function

When you need to assess KDM1A with attention to cellular organization, this antibody provides a focused option. KDM1A is a target that supports characterization of cellular state through expression and localization readouts. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol LSD1.

Experimental Applications

In many projects, target-level measurements help link perturbations to downstream phenotypes. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

In practice, target tracking can support localization mapping, relative quantification, and interaction-focused experiments without locking you into a single readout strategy.

Common experimental questions that benefit from target tracking include:

• interpretation alongside orthogonal readouts
• baseline versus stimulated condition comparisons
• cross-sample normalization strategies

Workflow Perspective

Because fixation can mask epitopes, fixed-section oriented formats aim to maintain recognition after standard deparaffinization and retrieval steps. To keep comparisons consistent, align sample preparation steps and define a clear baseline for each series.

If your study spans multiple model systems, it can help to define a shared reference condition for KDM1A so cross-sample contrasts stay meaningful.

When interpreting KDM1A, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

As you refine hypotheses around KDM1A, the fixed-section format helps keep conclusions tied to preparation context.